Synlogic Stock (NASDAQ:SYBX)

Forecast Ownership Financials Chart

Previous Close

$0.67

52W Range

$0.54 - $1.87

50D Avg

$0.70

200D Avg

$0.93

Market Cap

$7.84M

Avg Vol (3M)

$10.43K

Beta

0.54

Div Yield

-

SYBX Company Profile

Synlogic, Inc. does not have significant operations. It was previously engaged in the discovery and development of synthetic biotics to treat metabolic diseases. Synlogic, Inc. is based in Winchester, Massachusetts.

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

1

IPO Date

Sep 30, 2015

Website

SYBX Performance

SYBX Financial Summary

	Dec 25	Dec 24	Dec 23
Revenue	-	$8.00K	$3.37M
Operating Income	$-4.01M	$-40.95M	$-55.16M
Net Income	$-1.00M	$-23.36M	$-57.28M
EBITDA	$-4.01M	$-22.06M	$-55.31M
Basic EPS	$-0.08	$-1.92	$-8.81
Diluted EPS	$-0.08	$-1.92	$-8.81

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts

Q2 22Aug 11, 22 | 8:30 AM

Q1 22May 12, 22 | 8:30 AM

Q4 21Mar 17, 22 | 8:30 AM

Peer Comparison

Ticker	Company
CUPR	Cuprina Holdings (Cayman) Limited Class A Ordinary Shares
PCSA	Processa Pharmaceuticals, Inc.
LEXX	Lexaria Bioscience Corp.
BCTX	BriaCell Therapeutics Corp.
CRIS	Curis, Inc.
ALLR	Allarity Therapeutics, Inc.
CING	Cingulate Inc.